Model Awards - Fibrolamellar Cancer Foundation support laboratories and organizations that share human fibrolamellar carcinoma research models, helping researchers study the cancer and explore potential treatments.
Funder: Fibrolamellar Cancer Foundation
Due Dates: No fixed deadline stated
Funding Amounts: $10,000 per approved model deposited in the FCF collection
Summary: Incentive prizes support the sharing of human fibrolamellar carcinoma cell, organoid, and patient-derived xenograft models for research.
Key Information: An award requires validation, FCF approval, a deposit agreement, and deposit of the model.
The Fibrolamellar Cancer Foundation (FCF) offers incentive prizes to expand access to research models of fibrolamellar carcinoma (FLC), a rare cancer for which valid experimental systems are scarce. The awards recognize laboratories or organizations that make patient-derived xenograft (PDX) models or stable cell and organoid lines of human FLC available to the research community.
FCF aims to build collections of well-characterized models that reflect the tumors from which they were derived. Wider access to these models can help researchers investigate cancer biology and genetic pathways, screen drugs, and explore potential treatments in preclinical settings.